Sherman Diagnostics
Pathogen Detection Technology
Startup Seed Health Tech & Life Sciences Est. 2020
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
2 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
88/100
About
Sherman Diagnostics has developed a diagnostic technology designed to detect pathogens using any biological sample. The company’s technology can be used for rapid testing of infectious diseases such as coronavirus economically and efficiently, enabling users to affordably detect DNA/RNA-based pathogens.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Core Technology
BiologicalsMolecules
Target Customer
Healthcare & Life SciencesHealthcareLaboratoriesPatientsMedical Devices IndustryMedical Equipment
Business Model
B2BB2B2C
Tags
infectious-diseasediagnosticsmedical-devices
Funding & Events
Oct 2020
Undisclosed Round Undisclosed
Sanara Ventures
May 2024
Undisclosed Round Undisclosed
Sanara Ventures
Details
Product Stage
Released
Employees
1-10
Exact Count
1
Founded
2020
Registrar
516179298
Locations
Zarhin St 13, Ra'anana, Israel
Links
Admin
Last Update
Jun 26, 2024
Verified by
Yanina Wainscheinker
Missing
video or image, news, markets, not claimed
Team (2)
Menny Sherman
Co-founder & CEO
Founder
Eilon Sherman
Co-founder & CTO
Founder
Internal
Created by
Ayelet Levi Shinebox (yayhosh@gmail.com)
Created
2023-02-15T00:00:00.000Z